Comparative efficacy and safety of Chinese patent medicines of acute ischemic stroke: A network meta-analysis

BACKGROUND: Acute ischemic stroke (AIS) is characterized by high morbidity, disability, mortality, recurrence, and economic burden. Clinical trials have demonstrated that the clinical efficacy of combining oral Chinese patent medicines (CPMs) with chemical drugs (CDs) is better than that of CDs alon...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Yuan, Cao, Shan, Wang, Shu-fei, Hou, Xin-li, Guo, Si-si, Gou, Xiao-jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
5900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10589523/
https://www.ncbi.nlm.nih.gov/pubmed/37861561
http://dx.doi.org/10.1097/MD.0000000000035129

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10589523/
https://www.ncbi.nlm.nih.gov/pubmed/37861561
http://dx.doi.org/10.1097/MD.0000000000035129

Ejemplares similares